Dental amalgam, mercury toxicity, and renal autoimmunity

Journal of Environmental Pathology, Toxicology and Oncology

Volumn 27, Issue 2, 2008, Pages 147-155

  Guzzi, Gianpaolo ^a   Fogazzi, Giovanni Battista ^b   Cantu, Mariadele ^c   Minoia, Claudio ^d   Ronchi, Anna ^d   Pigatto, Paolo D ^e   Severi, Gianluca ^f  

^a Italian Association for Metals and Biocompatibility Research AIRMEB   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c TREVIGLIO HOSPITAL   (Italy)

^d IRCCS   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adverse events; Allergy to mercury; Antiglomerular basement membrane; Kidney autoimmunity; Mercury amalgam fillings; Mercury toxicity; Mercury induced autoimmune glomerulonephritis; Mercury induced kidney autoimmune disease; Renotoxicity

Indexed keywords

DENTAL ALLOY; THIOMERSAL;

ADULT; AGED; APHTHOUS ULCER; ARTICLE; AUTOIMMUNITY; BURNING MOUTH SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LICHEN PLANUS; LYMPHOCYTE TRANSFORMATION TEST; MALE; MERCURIALISM; PATCH TEST; PRIORITY JOURNAL;

EID: 45549091765     PISSN: 07318898     EISSN: None     Source Type: Journal    
DOI: 10.1615/JEnvironPatholToxicolOncol.v27.i2.70     Document Type: Article

References (47)

1. Goyer RA, Clarkson TW. Toxic effects of metals. In: Klaassen CD. Casarett & Doull's toxicology: the basic science of poisons. 6th ed., New York: MCGraw Hill; 2001. p. 811-67.
2. Buchet JP, Roels H, Bernard A, Lauwerys R,. Assessment of renal function of workers exposed to inorganic lead, calcium or mercury vapor. J Occup Med. 1980;22:741-50.
3. Hua J, Pelletier L, Berlin M, Druet P. Autoimmune glomerulonephritis induced by mercury vapour exposure in the Brown Norway rat. Toxicology. 1993;30:79:119-29.
4. Barregard L, Enestrom S, Ljunghusen O, Wieslander J, Hultman P. A study of autoantibodies and circulating immune complexes in mercury-exposed chloralkali workers. Int Arch Occup Environ Health. 1997;70:101-6.
5. Hultman P, Lindh U, Horsted-Bindslev P. Activation of the immune system and systemic immune-complex deposits in Brown Norway rats with dental amalgam restorations. J Dent Res. 1998;77:1415-25.
6. Bigazzi PE. Metals and kidney autoimmunity. Environ Health Perspect. 1999;107:753-65.
7. Guzzi G, Grandi M, Cattaneo C, Calza S, Minoia C, Ronchi A, Gatti A, Severi G. Dental amalgam and mercury levels in autopsy tissues: food for thought. Am J Forensic Med Pathol. 2006;27:42-5.
8. Lorscheider FL, Vimy MJ, Summers AO. Mercury exposure from "silver" tooth fillings: emerging evidence questions a traditional dental paradigm. FASEB J. 1995;9:504-8.
9. Clarkson TW. The three modern faces of mercury. Environ Health Perspect. 2002;110 Suppl 1:11-23.
10. Warfvinge K, Hansson H, Hultman P. Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice: dose-response studies. Toxicol Appl Pharmacol. 1995;132:299-309.
11. Rowley B, Monestier M. Mechanisms of heavy-metal-induced autoimmunity. Mol Immunol. 2005;42:833-8.
12. Havarinasab S, Hultman P. Organic mercury compounds and autoimmunity. Autoimmun Rev. 2005;4:270-5.
13. Hultman P, Johansson U, Turley SJ, Lindh U, Enestrom S, Pollard KM. Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice. FASEB J. 1994;8:1183-90.
14. Mathieson PW, Thiru S, Oliveira DB. Mercuric chloride-treated brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab Invest. 1992;67:121-9.
15. Zalups RK. Molecular interactions with mercury in the kidney. Pharmacol Rev. 2000;52:113-43.
16. McCabe MJ Jr, Eckles KG, Langdon M, Clarkson TW, Whitekus MJ, Rosenspire AJ. Attenuation of CD95-induced apoptosis by inorganic mercury: caspase-3 is not a direct target of low levels of Hg2+. Toxicology Letters. 2005;155:161-70.
17. Silbergeld EK, Silva IA, Nyland JF. Mercury and autoimmunity: implications for occupational and environmental health. Toxicol Appl Pharmacol. 2005;207 Suppl 2:282-92.
18. Nieto E, Escudero E, Navarro E, Yanez-Mo M, Martin A, Perez de Lema G, Sanchez-Madrid F, Mampaso F. Effects of mycophenolate mofetil in mercury-induced autoimmune nephritis. J Am Soc Nephrol. 2002;13:937-45.
19. Silva IA, Nyland JF, Gorman A, Perisse A, Ventura AM, Santos EC, Souza JM, Burek CL, Rose NR, Silbergeld EK Mercury exposure, malaria, and serum antinuclear/antinucleolar antibodies in Amazon populations in Brazil: a cross-sectional study. Environ Health. 2004;3:11.
20. Druet E, Sapin C, Gunther E, Feingold N, Druet P. Mercuric chloride-induced anti-glomerular basement membrane antibodies in the rat: genetic control. Eur. J. Immunol. 1977;7:348-51.
21. Pelletier L, Pasquier R, Vial MC, Mandet C, Moutier R, Salomon JC, Druet P. Mercury-induced autoimmune glomerulonephritis: requirement for T-cells. Nephrol Dial Transplant. 1987;1:211-8.
22. Hinglais N, Pelletier L, Vial MC, Sapin C, Bascou C, Bariety J, Kelley V, Druet P. Effect of prostaglandin E1 in brown Norway rats with mercury-induced autoimmune disease. Clin Immunol Immunopathol. 1986;40:401-9.
23. Sapin C, Druet E, Druet P. Induction of anti-glomerular basement membrane antibodies in the Brown-Norway rat by mercuric chloride. Clin Exp Immunol.1977;28:173-9.
24. Hirszel P, Michaelson JH, Dodge K, Yamase H, Bigazzi PE. Mercury-induced autoimmune glomerulonephritis in inbred rats. II. Immunohistopathology, histopathology and effects of prostaglandin administration. Surv Synth Pathol Res. 1985;4:412-22.
25. Nangaku M, Shankland SJ, Couser WG. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol. 2005;16:1195-204.
26. Herrstrom P, Hogstedt B, Aronson S, Holmen A, Rastam L. Acute glomerulonephritis, Henoch-Schonlein purpura and dental amalgam in Swedish children: a case-control study. Sci Total Environ. 1996;191:277-82.
27. Enestrom S, Hultman P. Does amalgam affect the immune system? A controversial issue. Int Arch Allergy Immunol. 1995;106:180-203.
28. Minoia C, Nucera A, Merlini C, Ronchi A, Gatti A, Angeleri S, Grassi M, Guzzi G. Estimates of mercury exposure in dental office: environmental and biological monitoring of mercury assessment among dental team. RMZ & Materials and Geoenvironment. 2004;51:136-40.
29. Salama AD, Levy JB, Lightstone L, Pusey CD. Goodpasture's disease. Lancet. 2001; 358:917-20.
30. Hudson BG, Tryggvason K, Sundaramoorthy M, Neilson EG. Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003;348:2543-56.
31. Andrassy K, Küster S, Waldherr R, Ritz E. Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course. Nephron. 1991;59:206-12.
32. Ang C, Savige J, Dawbom J, Miach P, Heale W, Clarke B, Sinclair RS. Anti-glomerular basement membrane (GBM)-antibody-mediated disease with normal renal function. Nephrol Dial Transplant. 1998;13:935-9.
33. Cui Z, Wang HY, Zhao Mh Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int 2006;69:894-9.
34. Martinsson K, Hultman P. The role of Fc-receptors in murine mercury-induced systemic autoimmunity. Clin Exp Immunol. 2006;144:309-18.
35. Aymaz S, Gross O, Krakamp B, Ortmann M, Dienes HP, Weber M. Membranous nephropathy from exposure to mercury in the fluorescent-tube-recycling industry. Nephrol Dial Transplant. 2001;16:2253-5.
36. Kazantzis G. The role of hypersensitivity and the immune response in influencing susceptibility to metal toxicity. Environ Health Perspect. 1978;25:111-8.
37. Magos L, Clarkson TW. Overview of the clinical toxicity of mercury. Ann Clin Biochem. 2006; 43: 257-68.
38. Ara J, Robert J, Mirapeix E, Botey A, Darnell A. High prevalance of antithyroid antibodies in antiglomerular basement membrane antibody-mediated disease. J Nephrol. 2000;13:65-7.
39. Ellingsen DG, Efskin J, Berg KJ, Gaarder PI, Thommassen Y. Renal and immunologic markers for chloralkali workers with low exposure to mercury vapor. Scand J Environ Health. 2000;26:427-35.
40. Goering PL, Morgan DL, Ali SF. Effects of mercury vapor inhalation on reactive oxygen species and antioxidant enzymes in rat brain and kidney are minimal. J Appl Toxicol. 2002;22:167-72.
41. Mortada WL, Sobh MA, El-Defrawy MM, Farahat SE. Mercury in dental restoration: is there a risk of nephrotoxicicty? J Nephrol. 2002;15:171-6.
42. Barregard L, Trachtenberg F, McKinlay S. Renal Effects of Dental Amalgam in Children: The New England Children's Amalgam Trial. Environ Health Perspect. 2008;116:394-99.
43. Mutter J, Naumann J, Sadaghiani C, Walach H, Drasch G. Amalgam studies: disregarding basic principle of mercury toxicity. Int J Hyg Environ Health. 2004;207:391-7.
44. Tubbs RR, Gephardt GN, McMahon JT, Pohl MC, Vidt DG, Barenberg SA, Valenzuela R. Membranous glomerulonephritis associated with industrial mercury exposure. Study of pathogenetic mechanisms. Am J Clin Pathol. 1982;77:409-13.
45. Langworth S, Elinder CG, Sundquist KG, Vesterberg O. Renal and immunological effects of occupational exposure to inorganic mercury. Br J Ind Med. 1992;49:394-401.
46. Lauwerys R, Bernard A, Roels H, Buchet JP, Gennart JP, Mahieu P, Foidart JM. Anti-laminin antibodies in workers exposed to mercury vapour. Toxicol Lett. 1983;17:113-6.
47. Pigatto PD, Mazzi B, Fleischhauer K, Guzzi G et al. Linking allergy to mercury to HLA and burning mouth syndrome. J Eur Acad Dermatol Venereol. 2007;21:1118-20.